These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2829701)

  • 41. The liver and steroid hormones.
    Freedman A
    Med J Aust; 1977 Feb; 1(7):200-1. PubMed ID: 191735
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatocellular carcinoma: molecular biology, etiology and animal models.
    Dusheiko G
    Gastroenterol Clin North Am; 1987 Dec; 16(4):575-90. PubMed ID: 2831151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical feminisation and sex hormone concentrations in Nigerian men with cirrhosis with and without hepatocellular carcinoma.
    Olubuyide IO; Ola OS
    Br J Clin Pract; 1994; 48(2):70-2. PubMed ID: 8024993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
    Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
    Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity.
    Wake DJ; Strand M; Rask E; Westerbacka J; Livingstone DE; Soderberg S; Andrew R; Yki-Jarvinen H; Olsson T; Walker BR
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):440-6. PubMed ID: 17302881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Toxic hepatitis induced by steroids].
    Yamanaka M; Sano N; Itokazu K; Yokote M; Torii M; Miyake K
    Nihon Rinsho; 1985 Jun; 43(6):1180-6. PubMed ID: 3900471
    [No Abstract]   [Full Text] [Related]  

  • 48. Androgenic-anabolic steroid therapy and hepatocellular carcinoma.
    Henderson JT; Richmond J; Sumerling MD
    Lancet; 1973 Apr; 1(7809):934. PubMed ID: 4123858
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.
    Kalra M; Mayes J; Assefa S; Kaul AK; Kaul R
    World J Gastroenterol; 2008 Oct; 14(39):5945-61. PubMed ID: 18932272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.
    Yeh YT; Chang CW; Wei RJ; Wang SN
    Biomed Res Int; 2013; 2013():290575. PubMed ID: 23484104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term survival with tumor regression in androgen-induced liver tumors.
    McCaughan GW; Bilous MJ; Gallagher ND
    Cancer; 1985 Dec; 56(11):2622-6. PubMed ID: 2996742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benign liver tumor in a patient taking contraceptive steroids.
    Megaffin BB; Hardin CA
    J Kans Med Soc; 1976 Jun; 77(6):231-5, 245. PubMed ID: 178809
    [No Abstract]   [Full Text] [Related]  

  • 53. Sex steroid axes in determining male predominance in hepatocellular carcinoma.
    Zhang L; Wu J; Wu Q; Zhang X; Lin S; Ran W; Zhu L; Tang C; Wang X
    Cancer Lett; 2023 Feb; 555():216037. PubMed ID: 36563929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgen-associated hepatoma in a hemodialysis patient.
    Zevin D; Turani H; Cohen A; Levi J
    Nephron; 1981; 29(5-6):274-6. PubMed ID: 6275283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of sex hormones on liver tumor progression and regression in Myc/xmrk double oncogene transgenic zebrafish.
    Li H; Lu JW; Huo X; Li Y; Li Z; Gong Z
    Gen Comp Endocrinol; 2019 Jun; 277():112-121. PubMed ID: 30926469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [HEPATOCELLULAR CARCINOMA. GENDER ASPECTS OF CARCINOGENESIS].
    Shaposhnikov AV
    Eksp Klin Gastroenterol; 2016; (7):4-12. PubMed ID: 30284415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fulminant hepatic neoplasia after androgen therapy.
    Mokrohisky ST; Ambruso DR; Hathaway WE
    N Engl J Med; 1977 Jun; 296(24):1411-2. PubMed ID: 193011
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hepatic complications from steroid hormones].
    Chevrel B
    Nouv Presse Med; 1976 Sep; 5(30):1915. PubMed ID: 980706
    [No Abstract]   [Full Text] [Related]  

  • 59. Androgen associated hepatocellular carcinoma with an aggressive course.
    Gleeson D; Newbould MJ; Taylor P; McMahon RF; Leahy BC; Warnes TW
    Gut; 1991 Sep; 32(9):1084-6. PubMed ID: 1655591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Disorders of sex differentiation caused by exogenous sex hormones and endocrine disruptors].
    Ohyama K
    Nihon Rinsho; 2006 Jun; Suppl 2():533-8. PubMed ID: 16817459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.